These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19730973)

  • 1. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.
    Wiik A
    Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in ANCA-associated vasculitis.
    Wiik AS
    Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
    Savige J; Trevisin M; Pollock W
    J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
    Wada T
    Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What you should know about PR3-ANCA. An introduction.
    Wiik A
    Arthritis Res; 2000; 2(4):252-4. PubMed ID: 11094436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
    Avery TY; Bons J; van Paassen P; Damoiseaux J
    Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic approach to ANCA-associated vasculitides.
    Gaffo AL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):491-506. PubMed ID: 20688246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.
    Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K
    Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.
    Radice A; Bianchi L; Sinico RA
    Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L28. Relevance of detection techniques for ANCA testing.
    Elena C
    Presse Med; 2013 Apr; 42(4 Pt 2):582-4. PubMed ID: 23474049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory diagnostics of ANCA-vasculitis].
    Salamunić I; Kaliterna DM
    Reumatizam; 2013; 60(2):39-42. PubMed ID: 24979995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCA-Associated Vasculitis Pathogenesis: A Commentary.
    Gapud EJ; Seo P; Antiochos B
    Curr Rheumatol Rep; 2017 Apr; 19(4):15. PubMed ID: 28361331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 20. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
    Kettritz R
    Clin Exp Immunol; 2012 Sep; 169(3):220-8. PubMed ID: 22861361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.